Anti-inflammatory therapeutic approaches

Z. Szekanecz, G. Kerekes, Yehuda Shoenfeld

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Accelerated atherosclerosis and increased cardiovascular (CV) risk have become 3 major factors of mortality in inflammatory diseases. Most data have become avail-4 able in rheumatoid arthritis (RA), however, vasculopathies have also been 5 associated with spondylarthropathies (SpA), systemic lupus erythematosus (SLE), 6 antiphospholipid syndrome (APS), systemic sclerosis (SSc, scleroderma) and sys-7 temic vasculitides [1-19].

Original languageEnglish
Title of host publicationInflammation and Atherosclerosis
PublisherSpringer-Verlag Wien
Pages513-528
Number of pages16
Volume9783709103388
ISBN (Print)9783709103388, 3709103371, 9783709103371
DOIs
Publication statusPublished - Apr 1 2012

Fingerprint

Spondylarthropathies
Antiphospholipid Syndrome
Systemic Scleroderma
Vasculitis
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Atherosclerosis
Anti-Inflammatory Agents
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Szekanecz, Z., Kerekes, G., & Shoenfeld, Y. (2012). Anti-inflammatory therapeutic approaches. In Inflammation and Atherosclerosis (Vol. 9783709103388, pp. 513-528). Springer-Verlag Wien. https://doi.org/10.1007/978-3-7091-0338-8_26

Anti-inflammatory therapeutic approaches. / Szekanecz, Z.; Kerekes, G.; Shoenfeld, Yehuda.

Inflammation and Atherosclerosis. Vol. 9783709103388 Springer-Verlag Wien, 2012. p. 513-528.

Research output: Chapter in Book/Report/Conference proceedingChapter

Szekanecz, Z, Kerekes, G & Shoenfeld, Y 2012, Anti-inflammatory therapeutic approaches. in Inflammation and Atherosclerosis. vol. 9783709103388, Springer-Verlag Wien, pp. 513-528. https://doi.org/10.1007/978-3-7091-0338-8_26
Szekanecz Z, Kerekes G, Shoenfeld Y. Anti-inflammatory therapeutic approaches. In Inflammation and Atherosclerosis. Vol. 9783709103388. Springer-Verlag Wien. 2012. p. 513-528 https://doi.org/10.1007/978-3-7091-0338-8_26
Szekanecz, Z. ; Kerekes, G. ; Shoenfeld, Yehuda. / Anti-inflammatory therapeutic approaches. Inflammation and Atherosclerosis. Vol. 9783709103388 Springer-Verlag Wien, 2012. pp. 513-528
@inbook{35c66d591e134169af3f3ee0d0b21eb0,
title = "Anti-inflammatory therapeutic approaches",
abstract = "Accelerated atherosclerosis and increased cardiovascular (CV) risk have become 3 major factors of mortality in inflammatory diseases. Most data have become avail-4 able in rheumatoid arthritis (RA), however, vasculopathies have also been 5 associated with spondylarthropathies (SpA), systemic lupus erythematosus (SLE), 6 antiphospholipid syndrome (APS), systemic sclerosis (SSc, scleroderma) and sys-7 temic vasculitides [1-19].",
author = "Z. Szekanecz and G. Kerekes and Yehuda Shoenfeld",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/978-3-7091-0338-8_26",
language = "English",
isbn = "9783709103388",
volume = "9783709103388",
pages = "513--528",
booktitle = "Inflammation and Atherosclerosis",
publisher = "Springer-Verlag Wien",

}

TY - CHAP

T1 - Anti-inflammatory therapeutic approaches

AU - Szekanecz, Z.

AU - Kerekes, G.

AU - Shoenfeld, Yehuda

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Accelerated atherosclerosis and increased cardiovascular (CV) risk have become 3 major factors of mortality in inflammatory diseases. Most data have become avail-4 able in rheumatoid arthritis (RA), however, vasculopathies have also been 5 associated with spondylarthropathies (SpA), systemic lupus erythematosus (SLE), 6 antiphospholipid syndrome (APS), systemic sclerosis (SSc, scleroderma) and sys-7 temic vasculitides [1-19].

AB - Accelerated atherosclerosis and increased cardiovascular (CV) risk have become 3 major factors of mortality in inflammatory diseases. Most data have become avail-4 able in rheumatoid arthritis (RA), however, vasculopathies have also been 5 associated with spondylarthropathies (SpA), systemic lupus erythematosus (SLE), 6 antiphospholipid syndrome (APS), systemic sclerosis (SSc, scleroderma) and sys-7 temic vasculitides [1-19].

UR - http://www.scopus.com/inward/record.url?scp=84910024114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910024114&partnerID=8YFLogxK

U2 - 10.1007/978-3-7091-0338-8_26

DO - 10.1007/978-3-7091-0338-8_26

M3 - Chapter

AN - SCOPUS:84910024114

SN - 9783709103388

SN - 3709103371

SN - 9783709103371

VL - 9783709103388

SP - 513

EP - 528

BT - Inflammation and Atherosclerosis

PB - Springer-Verlag Wien

ER -